The Safety Profile of Liposomal Bupivacaine Use in Septorhinoplasty.

To evaluate the safety profile, including adverse drug reactions and operative complications, of liposomal bupivacaine (LB) use for local anesthesia during functional septorhinoplasty. Retrospective review. A database query was conducted for patients >18 years of age who underwent septorhinoplasty from January 1, 2019, to August 1, 2020. Adverse drug reactions and postoperative outcomes were compared between patients who received locally administered LB and patients who received standard local anesthetic at the completion of the surgery. A total of 95 cases were included in our data analysis. No significant differences were found in adverse reactions overall (6.3% vs. 3.1%,  = 0.51) or complications, including rate of infection (3.2% vs. 3.1%,  = 1), cartilage warping (1.6% vs. 0%,  = 1), graft resorption (0% vs. 0%,  = 1), septal hematoma (0% vs. 0%,  = 1), and need for revision surgery (4.8% vs. 3.1%,  = 1) between LB and control groups. LB demonstrated an acceptable safety profile when compared with standard local anesthetics during septorhinoplasty, with no significant difference in systemic or local adverse drug reactions or postoperative complications.